Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo
| Autor: | Hiroko Toyota, Junichiro Mizuguchi, Noriko Yanase, Mitsunori Harada, Takayuki Yoshimoto, Yasuki Kato |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Cytotoxicity
Immunologic Cancer Research Cellular immunity Thymoma Ovalbumin medicine.medical_treatment Biology Immune system Nanocapsules Antigen Cell Line Tumor medicine Animals Cytotoxic T cell Cell Proliferation Interleukin-7 Vaccination technology industry and agriculture General Medicine Immunotherapy respiratory system Xenograft Model Antitumor Assays Tumor antigen Mice Inbred C57BL Oncology Cell culture Immunology Cancer research Female Immunologic Memory A431 cells |
| Zdroj: | Oncology Reports. 33:292-296 |
| ISSN: | 1791-2431 1021-335X |
| DOI: | 10.3892/or.2014.3603 |
| Popis: | Immunotherapy has gained special attention due to its specific effects on tumor cells and systemic action to block metastasis. We recently demonstrated that ovalbumin (OVA) conjugated to the surface of nanoparticles (NPs) (OVA‑NPs) can manipulate humoral immune responses. In the present study, we aimed to ascertain whether vaccination with OVA-NPs entrapping IL-7 (OVA-NPs-IL-7) are able to induce antitumor immune responses in vivo. Pretreatment with a subcutaneous inoculation of OVA-NPs delayed the growth of thymic lymphoma cells expressing a model tumor antigen OVA (E.G7-OVA), and OVA-NPs-IL-7 substantially blocked the growth of E.G7-OVA tumor cells, although NPs-IL-7 alone had a meager effect, as assessed by the mean tumor size and the percentage of tumor-free mice. However, pretreatment with OVA-NPs-IL-7 failed to reduce the growth of parental thymic tumor cells, suggesting that the antitumor effect was antigen-specific. A tetramer assay revealed that vaccination with OVA-NPs-IL-7 tended to enhance the proportion of cytotoxic T cells (CTLs) specific for OVA. When the tumor-free mice inoculated with OVA-NPs-IL-7 plus EG.7 cells were rechallenged with E.G7-OVA cells, they demonstrated reduced growth compared with that in the control mice. Thus, a single subcutaneous injection of OVA-NPs-IL-7 into mice induced tumor-specific and also memory-like immune responses, resulting in regression of tumor cells. Antigens on NPs entrapping IL-7 would be a promising carrier to develop and enhance immune responses, including humoral and cellular immunity as well as a method of drug delivery to a specific target of interest. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|